New Issue: Orbus Pharma arranges C$8 million private placement of common stock

By Devika Patel

Knoxville, Tenn., Feb. 5 - Orbus Pharma Inc. said it plans an C$8 million private placement of stock.

The company will sell up to 533,333,333 common shares at C$0.015 apiece. Of the shares, 308,286,127 will be sold to Nanjing Sanhome Pharmaceutical Co., Ltd. for C$4.62 million.

Proceeds will be used for development plans, to pay liabilities and to cover general working capital requirements.

Orbus is a pharmaceutical company based in Markham, Ont.

Issuer:	Orbus Pharma Inc.
Issue:	Common shares
Amount:	C$8 million
Shares:	533,333,333
Price:	C$0.015
Warrants:	No
Investor:	Nanjing Sanhome Pharmaceutical Co., Ltd. (for C$4,624,292)
Pricing date:	Feb. 5
Stock symbol:	TSX Venture: ORB.H
Stock price:	C$0.015 at close Feb. 4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.